2 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Malignant Digestive System Neoplasm: new trials by email Literature Review of Malignant Digestive System Neoplasm trials Research Report on Malignant Digestive System Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy Biospecimen Collection, Capecitabine, Diltiazem Hydrochloride - Malignant Digestive System Neoplasm | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 60 | 2026-04-30 | 2026-06-02 |
| GCC Agonist Signal in the Small Intestine Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy - Barrett Esophagus, Gastroesophageal Reflux Disease | Phase 1 | Completed | University of Wisconsin, Madison | 43 | 2022-11-30 | 2026-04-07 |
| Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors Alisertib, Fluorouracil, Laboratory Biomarker Analysis - Malignant Digestive System Neoplasm | Phase 1 | Completed | National Cancer Institute (NCI) | 14 | 2015-08-27 | 2018-10-09 |
Gastrointestinal Neoplasms (3) · Barrett Esophagus (1) · Gastroesophageal Reflux (1)
Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Deglutition Disorders (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1) · Precancerous Conditions (1)
Fluorouracil (2) · Specimen Handling (2) · dehydroftorafur (2) · Biopsy (1) · Capecitabine (1) · Diltiazem (1) · Electrocardiography, Ambulatory (1) · Endoscopy, Digestive System (1) · Isosorbide (1) · Leucovorin (1) · MLN 8237 (1) · Oxaliplatin (1) · isosorbide-5-mononitrate (1) · linaclotide (1) · plecanatide (1)
Mayo Clinic (1) · National Cancer Institute (NCI) (1) · University of Wisconsin, Madison (1)
United States (3)
David S Weinberg (1) · Joerg Herrmann, MD (1) · Laura Goff (1)
P30CA014520 (1), P30CA016359 (1), R01CA131225 (1), UG1CA242635 (1), UM1CA186689 (1)